loadpatents
Patent applications and USPTO patent grants for RHODES; Kenneth.The latest application filed is for "compositions and methods for the treatment and prevention of neurological disorders".
Patent | Date |
---|---|
Compositions And Methods For The Treatment And Prevention Of Neurological Disorders App 20220110920 - ARON; Rebecca ;   et al. | 2022-04-14 |
Methods For The Treatment Of Neurological Disorders App 20220040167 - VINCENT; Benjamin Matteson ;   et al. | 2022-02-10 |
Compositions and methods for the treatment and prevention of neurological disorders Grant 11,241,417 - Aron , et al. February 8, 2 | 2022-02-08 |
Methods for the treatment of neurological disorders Grant 10,973,810 - Vincent , et al. April 13, 2 | 2021-04-13 |
Compounds And Uses Thereof App 20200262828 - LUCAS; Matthew ;   et al. | 2020-08-20 |
Methods For The Treatment Of Neurological Disorders App 20200222400 - RHODES; Kenneth ;   et al. | 2020-07-16 |
Compounds And Uses Thereof App 20200010462 - LUCAS; Matthew ;   et al. | 2020-01-09 |
Compositions And Methods For The Treatment And Prevention Of Neurological Disorders App 20190388397 - ARON; Rebecca ;   et al. | 2019-12-26 |
Methods For The Treatment Of Neurological Disorders App 20180193325 - VINCENT; Benjamin ;   et al. | 2018-07-12 |
Prodrugs And Drugs App 20160115540 - Fontenot; Jason ;   et al. | 2016-04-28 |
A Method Of Reducing Brain Amyloid Plaques Using Anti-ab Antibodies App 20150315267 - Bussiere; Thierry ;   et al. | 2015-11-05 |
Methods Of Inhibiting Pro Matrix Metalloproteinase Activation App 20120302573 - JACKSON; Paul Francis ;   et al. | 2012-11-29 |
Heterocyclic Derived Metalloprotease Inhibitors App 20100279986 - ZHANG; Yue-Mei ;   et al. | 2010-11-04 |
Heterocyclic derived metalloprotease inhibitors Grant 7,803,793 - Zhang , et al. September 28, 2 | 2010-09-28 |
Nucleic acids encoding potassium channel interactors Grant 7,556,938 - Rhodes , et al. July 7, 2 | 2009-07-07 |
Human 9q polypeptides method Grant 7,439,029 - Rhodes , et al. October 21, 2 | 2008-10-21 |
Heterocyclic Derived Metalloprotease Inhibitors App 20080103129 - Zhang; Yue-Mei ;   et al. | 2008-05-01 |
Matrix Metalloprotease Inhibitors App 20080085893 - YANG; Shyh-Ming ;   et al. | 2008-04-10 |
Methods for treating cardiovascular disorders Grant 7,115,381 - Rhodes , et al. October 3, 2 | 2006-10-03 |
Potassium channel interactors and uses therefor Grant 7,078,481 - Rhodes , et al. July 18, 2 | 2006-07-18 |
Potassium channel interacting polypeptides and uses thereof Grant 7,041,795 - Rhodes , et al. May 9, 2 | 2006-05-09 |
Potassium Channel Interactors Polypeptides And Uses Thereof App 20050277761 - Rhodes, Kenneth ;   et al. | 2005-12-15 |
Potassium channel interactors and uses therefor Grant 6,689,581 - Rhodes , et al. February 10, 2 | 2004-02-10 |
Potassium channel interactors and uses therefor App 20030119102 - Rhodes, Kenneth ;   et al. | 2003-06-26 |
Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunit App 20030024001 - Kwak, Seung P. ;   et al. | 2003-01-30 |
Methods For Treating Cardiovascular Disorders App 20020019020 - RHODES, KENNETH ;   et al. | 2002-02-14 |
Combination cigarette pack and lighter holder Grant 5,630,503 - Rhodes , et al. May 20, 1 | 1997-05-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.